Occurrence of &bgr;-blockers and &bgr;-agonists in hospital effluents and their receiving rivers in southern Taiwan
Authors:
- Tsung-Hsien YuTYTsung-Hsien Yu
- Angela Yu-Chen LinALAngela Yu-Chen Lin
- Xiao-Huan WangXWXiao-Huan Wang
- Cheng-Fang LinCLCheng-Fang Lin
Open Access
- 1 August 2011
- journal article
- Published by Elsevier in Desalination and Water Treatment
- Vol. 32 (1-3) , 49-56
Abstract
The occurrence of pharmaceuticals in aquatic environments has been of increasing concern in developed and developing countries. The major sources of pharmaceuticals in aqueous systems are waste streams from hospital effluents and excretion (in both metabolized and un-metabolized forms) from humans and animals. This study investigated the occurrence and distribution of four β-blockers (propranolol, atenolol, metoprolol and acebutolol) and four β-agonists (tulobuterol, salbutamol, clenbuterol and ractopamine) from three hospital effluents and four rivers in southern Taiwan. Analysis was performed via solid-phase extraction and liquid chromatography/tandem mass spectrometry. All targets were detected at least once in all collected samples. The most frequently detected compounds were propranolol, atenolol, acebutolol, and ractopamine, which were found in >70% of the collected samples. 83% of water samples contained three or more target compounds. Metoprolol was found in relatively higher concentrations (up to...Keywords
This publication has 21 references indexed in Scilit:
- Sustainable risk management of emerging contaminants in municipal wastewatersPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2009
- Removal of pharmaceuticals in secondary wastewater treatment processes in TaiwanJournal of Hazardous Materials, 2009
- Occurrence of pharmaceuticals in Taiwan's surface waters: Impact of waste streams from hospitals and pharmaceutical production facilitiesScience of The Total Environment, 2009
- The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving watersWater Research, 2009
- Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in TaiwanChemosphere, 2008
- Elimination of pharmaceuticals in sewage treatment plants in FinlandWater Research, 2007
- Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewatersJournal of Chromatography A, 2006
- Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?Environmental Toxicology and Chemistry, 2004
- Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National ReconnaissanceEnvironmental Science & Technology, 2002
- Toxicity of Select Beta Adrenergic Receptor-Blocking Pharmaceuticals (B-Blockers) on Aquatic OrganismsArchives of Environmental Contamination and Toxicology, 2001